Molecular Analysis of Patients With Neuromuscular Disease

Conditions

• Duchenne/Becker Muscular Dystrophy
• Limb-girdle Muscular Dystrophy
• Neuromuscular; Disorder, Hereditary

Eligibility Criteria

Sex

ALL

Age

1 Week - 100 Years

Healthy Volunteers

Not accepted

Study Details

The purpose of this study is to identify new genes responsible for neuromuscular disorders and study muscle tissue of patient with known neuromuscular disease, as well as their family members. We are interested in recruiting many types of neuromuscular disease including; Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), and limb-girdle muscle dystrophy (LGMD). There are still many patients diagnosed with muscular dystrophy with no causative gene implicated in their disease. Using molecular genetics to unravel basis of these neuromuscular disorders will lead to more accurate diagnosis/prognosis of these disorders which will lead to potential therapies.

Key Dates

Start date

Jan 31, 2002

Status verified

Apr 2023

Primary completion

Dec 31, 2026

Completion

Dec 31, 2027

Study Design

Enrollment

1,000 participants (estimated)

Central Contacts

• Elicia A Estrella, MS, LCGC
  617-919-4552
  [email protected]
• Casie Genetti, MS,LCGC
  617-919-2169
  [email protected]

Locations (1)

Find similar trials in Boston, MA

Related Studies

• Congenital Muscle Disease Study of Patient and Family Reported Medical Information
  Recruiting · Cure CMD · Lakewood, California